SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021213
Filing Date
2022-11-02
Accepted
2022-11-02 16:04:12
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-20220930.htm   iXBRL 10-Q 5310357
2 EX-31.1 srpt-ex31_1.htm EX-31.1 15749
3 EX-31.2 srpt-ex31_2.htm EX-31.2 15862
4 EX-32.1 srpt-ex32_1.htm EX-32.1 11296
5 EX-32.2 srpt-ex32_2.htm EX-32.2 11105
  Complete submission text file 0000950170-22-021213.txt   14817799

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20220930_lab.xml EX-101.LAB 509181
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20220930_pre.xml EX-101.PRE 390736
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srpt-20220930_def.xml EX-101.DEF 235000
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20220930.xsd EX-101.SCH 71064
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srpt-20220930_cal.xml EX-101.CAL 77348
77 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20220930_htm.xml XML 2932712
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 221353948
SIC: 2834 Pharmaceutical Preparations